November 19, 2026

Boyce Avenue returns to Philippines for Valentine's tour 2027

Four-city tour to bring unforgettable love songs and acoustic covers 

to Manila, Cagayan De Oro, Davao and Cebu this February 2027

The “Boyce” are coming back to their second home – the Philippines. One of the biggest independent bands in the world – BOYCE AVENUE, is returning for their special Valentine’s Tour 2027, bringing their signature acoustic sound, heartfelt performances and timeless love songs. They will be performing in MANILA on Valentine’s Day, February 14 at the Araneta Coliseum, in CAGAYAN DE ORO on February 11 at The Atrium - Limketkai Mall, in DAVAO on February 13 at the SMX Convention Center, and in CEBU on February 16 at the Waterfront Hotel Ballroom. Joining them in all four cities are today’s exciting OPM artists – Angela Ken, Over October and Mariah Deborah.

 

Boyce Avenue is a Florida-based band whose name is a combination of two streets they grew up on in Sarasota. Known for their strong acoustic roots, the band consists of the three brothers - Alejandro (lead vocals, guitar, piano), Fabian (guitar, vocals) and Daniel (bass, percussion, vocals). The brothers began posting videos on YouTube in 2007 to great success. To date, they have amassed over 6.8 Billion YouTube views and over 16.8 Million YouTube subscribers, making their channel one of the most popular in the world. They are the most viewed independent band in the world (Guinness Book of World Records), and they have done many successful and viral musical collaborations with actors, influencers, and artists like Sarah Hyland (Modern Family), Bea Miller (X-Factor), Fifth Harmony, and Connie Talbot (Britain’s Got Talent). The band has continued to tour consistently, headlining shows in over 20 countries, and selling out legendary venues like the Royal Albert Hall in London and of course, the Araneta Coliseum in Manila.

 

Singer-songwriter Angela Ken captured the hearts of millions with her viral breakthrough hit “Ako Naman Muna”, along with fan favorites “It’s Okay Not To Be Okay” and “Pansinin Mo Naman Ako”. Indie pop-rock band Over October has become one of the rising names in the OPM scene with their hits “Ikot”, “Wait” and “123”. Completing the line-up is fast-rising singer-songwriter Mariah Deborah, best known for her viral hit “Na Para Bang”, captivating listeners with her soulful vocals and heartfelt music.

 

Catch Boyce Avenue – Valentine’s Tour 2027 with Angela Ken, Over October and Mariah Deborah in this one-of-a-kind concert experience featuring your favorite love songs, acoustic covers and OPM hits on Valentine’s week. Tickets go on-sale Saturday, November 28 at 12PM – MANILA via TicketNet.com.ph and TicketNet outlets, and CDO/DAVAO/CEBU via Ticketmelon.com. Presented by Wilbros Live.

 

Follow @WilbrosLive on Facebook, Twitter, Instagram and TikTok.

#BoyceAvenue #ValentinesTour2027 #AngelaKen #OverOctober #MariahDeborah 


HUAWEI WATCH GT 7 Series and HUAWEI WATCH D3: Spotlight Research on Cardiovascular Health and Blood Pressure Monitoring

HUAWEI is advancing its contributions to cardiovascular health research, with studies involving its wearable devices gaining recognition at two international medical conferences: the 19th Asia Pacific Heart Rhythm Society (APHRS) Scientific Session in South Korea and the 31st International Society of Hypertension Scientific Meeting and 17th Emirates Cardiac Society Annual Conference (ISH-ECS) in Dubai.

Meanwhile, at the ISH-ECS 2026, HUAWEI showcased its latest blood pressure monitoring innovations, including the HUAWEI WATCH D3, and highlighted its collaboration with the ISH through the newly established Wearable Blood Pressure Technology Innovation Fund.

Together, these developments reflect HUAWEI's continued efforts to bridge medical research and consumer technology, bringing advanced cardiovascular monitoring capabilities closer to everyday users. Through its HUAWEI WATCH GT 7 Pro and WATCH D3, the company aims to make heart health and blood pressure monitoring more accessible while supporting greater awareness of cardiovascular health.

Advancing Research Through Wearable Technology

 

At APHRS 2026, research involving HUAWEI wearables was cited in the 2026 Asia Pacific Atrial Fibrillation Guidelines, highlighting the potential of HUAWEI wearables in clinical settings while underscoring the growing role of smart devices in supporting proactive heart health monitoring. The study explored the links between sleep apnea, arrhythmia, blood pressure, and cardiovascular events using data from HUAWEI devices, proving the technology's capability to further cardiovascular research.[1]

 

Advancing Blood Pressure Monitoring Through Global Research

At the ISH-ECS 2026, HUAWEI also showcased its latest advancements in blood pressure monitoring in collaboration with the ISH through the Wearable Blood Pressure Technology Innovation Fund.

HUAWEI introduced its Minimally Disruptive Ambulatory Blood Pressure Monitoring (ABPM) research initiative at the conference. Developed in partnership with Ruijin Hospital, the study explores a hybrid approach that combines continuous photoplethysmography (PPG) monitoring with airbag-based blood pressure measurements to reduce reliance on cuff-based readings and make long-term blood pressure monitoring more comfortable and practical for users.

“Innovations like Minimally Disruptive ABPM and environmental monitoring reminders by HUAWEI Watch D3 may be inspiring for shaping a new direction on how future blood pressure management is automated and seamlessly embedded into daily life, via wearable devices,” said Professor Wang Jiguang, President of the Chinese Hypertension Association.

 

HUAWEI WATCH D3 and GT 7 Series: Advanced, All-in-One Health Tracking

 

 

The HUAWEI WATCH D3 and GT 7 Pro feature a one-tap Health Glance assessment, which analyzes crucial indicators like heart rate, heart rate variability (HRV), blood oxygen levels, arterial elasticity, and ECG data in a matter of seconds. The watch combines these metrics to generate a comprehensive report, helping users easily understand their overall health and spot potential risks early.

From early risk detection to continuous long-term management[2], HUAWEI remains committed to using smart technology to advance health awareness. By continuing to collaborate with global medical and research partners, HUAWEI aims to innovate digital health solutions and make advanced heart and blood pressure care accessible to everyone. 

To learn more, visit HUAWEI’s official website or social media accounts (Facebook | Instagram).

 



[1] Research findings are based on the specific study population and methodology and should not be interpreted as establishing causation or as a guarantee of individual health outcomes.

*Product features and availability may vary by country or region. Please refer to local product specifications for details.


[2] This product/feature is not a medical device. All monitoring data and results are for reference, general health or wellness only, and should not be used as a basis for medical diagnosis, prevention, monitoring, prediction, or treatment.

LinkWithin

Related Posts Plugin for WordPress, Blogger...
enjoying wonderful world